Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Aug 14, 2019, after the close
10-Q filed Aug 14, 2019, 45 days after period end · 0001171843-19-005480
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Revenue | $7.89K | $252.50K | $2.50K | $2.50K |
| Net Income | -$1.44M | -$627.05K | -$4.65M | -$3.85M |
| EPS Diluted |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$1.45 |
| -$0.83 |
| -$0.39 |
| -$0.47 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
